Connor, Clark & Lunn Investment Management (CC&L)
HOOK

Connor, Clark & Lunn Investment Management (CC&L)’s HOOKIPA Pharma HOOK Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,803
Closed -$14.6K – 1339
2022
Q4 		$14.6K Sell
1,803
-407
-18% -$4.41K ﹤0.01% 1168
2022
Q3 		$30K Buy
+2,210
New +$33.9K ﹤0.01% 1073
2021
Q4 		– Sell
-1,287
Closed -$76K – 1130
2021
Q3 		$76K Buy
+1,287
New +$93.3K ﹤0.01% 998

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s HOOK Position: Q1 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 1,803 shares — an estimated $14.6K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HOOK in Q3 2021 and held it in 3 quarters. The position peaked at $76K in Q3 2021. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,803 HOOKIPA Pharma shares in Q1 2023, an estimated $14.6K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s HOOKIPA Pharma position peaked at $76K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2023, filed 10 May 2023.